Access cutting-edge breast cancer treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Pittsburgh at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
Newly diagnosed post-menopausal women with clinical stage II-III, HR+HER2- breast cancer are eligible to a randomized trial, concurrently open at five US academic institutions. Patients receiving 4 months of standard neoadjuvant hormonal therapy with letrozole are randomly assigned to one of 4 arms of a trial testing focal hypo-fractionated RT alone or with immunotherapy combinations.
Sponsor: Weill Medical College of Cornell University
Check if you qualify for this breast cancer clinical trial in Pittsburgh, PA
If you're searching for breast cancer treatment options in Pittsburgh, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.